Replies to post #69211 on Biotech Values

[DewDiligence]

Re: AG's

>Just guessing - but I bet there are examples in the early generic period, though I cannot cite them<

Almost every US generic launched in the 1980s and 1990s is an example.

Authorized generics slide through a loophole in the Hatch-Waxman act, and it took drug companies a long time to recognize that the loophole existed.